Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.9%

1 terminated/withdrawn out of 112 trials

Success Rate

95.7%

+9.2% vs industry average

Late-Stage Pipeline

20%

22 trials in Phase 3/4

Results Transparency

9%

2 of 22 completed trials have results

Key Signals

7 recruiting2 with results

Enrollment Performance

Analytics

N/A
33(50.0%)
Phase 4
21(31.8%)
Early Phase 1
5(7.6%)
Phase 2
3(4.5%)
Phase 1
3(4.5%)
Phase 3
1(1.5%)
66Total
N/A(33)
Phase 4(21)
Early Phase 1(5)
Phase 2(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (112)

Showing 20 of 112 trials
NCT07230171Not ApplicableRecruiting

The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia

Role: collaborator

NCT07565623Not ApplicableNot Yet Recruiting

Prevention of AIDS With Opportunistic Infection Paradoxical IRIS

Role: collaborator

NCT07544121Not ApplicableNot Yet Recruiting

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

Role: collaborator

NCT07526363Not Yet Recruiting

Real-world Cohort Study of Antiretroviral Therapy in HIV Patients With Opportunistic Infections

Role: collaborator

NCT07341854Not ApplicableNot Yet Recruiting

Dexamethasone Palmitate for Postoperative Pain

Role: collaborator

NCT07481032Not ApplicableNot Yet Recruiting

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

Role: collaborator

NCT05042245Phase 4Completed

The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

Role: collaborator

NCT06980636Phase 4Recruiting

A Trial of Shengmai Liquid for Long COVID Fatigue.

Role: collaborator

NCT04896255Recruiting

Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

Role: collaborator

NCT07186621Phase 3Recruiting

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

Role: collaborator

NCT06890897Not ApplicableRecruiting

Esketamine Combined Pulsed Radiofrequency for Acute/Subacute Zoster-associated Trigeminal Neuralgia

Role: collaborator

NCT06896994Not ApplicableRecruiting

Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia

Role: collaborator

NCT06914180Not ApplicableNot Yet Recruiting

Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia

Role: collaborator

NCT06914193Not ApplicableNot Yet Recruiting

Esketamine Combined With PRF of DRG for Postherpetic Neuralgia

Role: collaborator

NCT06914206Not ApplicableNot Yet Recruiting

Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain

Role: collaborator

NCT06777173Not ApplicableEnrolling By Invitation

Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

Role: lead

NCT06773221Not ApplicableNot Yet Recruiting

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Role: collaborator

NCT06642740Enrolling By Invitation

Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia

Role: lead

NCT05659602Not ApplicableCompleted

A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

Role: lead

NCT04011033Phase 2Completed

Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC

Role: collaborator